Mvasi 55513-0207-21
Generic: Bevacizumab-Awwb
- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 1, 2018
- Listing Expires
- December 31, 2027
- Application
- BLA761028
Need to source Mvasi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bevacizumab | 400 mg/16mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Selected Package
55513-0207-21Selected1 VIAL in 1 CARTON (55513-207-21) / 16 mL in 1 VIAL
Other packages for this product(1)
1 VIAL in 1 CARTON (55513-207-01) / 16 mL in 1 VIAL